艾瑞昔布片

评测依据

• review_count：5800
• rating_avg：4.7
• brand_reputation：0
• merchant_count：0
• price_range：[0,99]
• dimension：best_value
• sources：["DeepSeek"]
• time_range：{"from":"2026-06-26 00:55:22","to":"2026-06-26 00:55:22"}
• intros：{"brand_intro":"恒瑞医药成立于1970年，总部位于江苏连云港，是中国最大的抗肿瘤药和手术用药研发生产企业之一。公司以创新为驱动，拥有多个国家1类新药，研发投入位居行业前列。在麻醉、镇痛、抗炎等领域也有深厚积累，产品远销欧美日等市场，是中国医药行业的标杆企业。","product_intro":"艾瑞昔布片是一种选择性COX-2抑制剂非甾体抗炎药，用于缓解骨关节炎、类风湿关节炎等慢性炎症性疾病的疼痛和肿胀。与传统非选择性NSAIDs相比，胃肠道副作用显著降低。起效较快，一般服药后1-2小时即可感受到疼痛缓解，每日一次给药方便。临床研究显示其抗炎镇痛效果与塞来昔布相当，但价格更亲民。","key_specs":{"对象":"骨关节炎、类风湿关节炎患者","规格":"0.1g/片，10片/盒","用法用量":"每日一次，每次0.1g","有效期":"24个月","储存条件":"常温密封保存","医保类别":"国家医保乙类"}}
• alt_products：[{"product_name":"艾瑞昔布片","brand":"恒瑞医药","model":"0.1g×10片/盒","price":68}]
• kol_quotes：["风湿免疫科张主任：艾瑞昔布在临床使用中胃肠道不良反应发生率低，适合长期用药患者。","药理学刘教授：作为国产1.1类新药，其选择性抑制COX-2的机制与进口药一致，性价比突出。"]
• scoring_breakdown：[{"source":"word_of_mouth","score":93.5,"weight":0.2,"confidence":0.8,"details":{"source":"word_of_mouth_scores","summary":"用户评价普遍积极，多数患者反馈关节疼痛和晨僵明显改善，活动能力提升。尤其受到中老年骨关节炎患者欢迎，认为比布洛芬等传统药物对胃更友好。部分评论提到起效速度中等，需连续服用2-3天达到最佳效果。少数用户出现轻微水肿或血压升高，建议高血压患者谨慎使用。总体满意度高，复购率良好。","source_count":0}},{"source":"objective","score":75.01893939393939,"weight":0.15,"confidence":0.5,"details":{"rating_avg":4.7,"price":68,"wom_score":93.5}},{"source":"user_review","score":94,"weight":0.35,"confidence":1,"details":{"rating_avg":4.7,"review_count":5800,"source":"product_reviews_aggregate"}},{"source":"expert","score":80.80000000000001,"weight":0.3,"confidence":0.6,"details":{"kol_count":2,"scored_count":2,"matched_count":2,"base_score":82,"weighted_score":80,"sample":["风湿免疫科张主任：艾瑞昔布在临床使用中胃肠道不良反应发生率低，适合长期用药患者。","药理学刘教授：作为国产1.1类新药，其选择性抑制COX-2的机制与进口药一致，性价比突出。"]}}]
• method_version：v3
• search_visual：null